Hip Replacement Implants Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,850	115 Pages	Fortune Business Insights Pvt. Ltd.	October, 2024	FOB19224330

Best Price Guarantee
Price	from $4,850
Length	115 Pages
Publisher	Fortune Business Insights Pvt. Ltd.
Published Date	October, 2024
SKU	FOB19224330

Hip Replacement Implants Market

Growth Factors of Hip Replacement Market

The hip replacement market size was reached at a value of USD 7.72 billion in 2023, and the market is now projected to grow from USD 8.05 billion in 2024 to USD 11.59 billion by 2032, exhibiting a CAGR of 4.7% during the forecast period of 2023-2032.

Government has put restrictions on social gatherings, events and moving out from home which make the people homesick. Numerous companies are encountering hurdles due to covid pandemic as the outbreak situation has curtailed production and supply chain which has hindered the pneumonia testing market switched to treating covid patients as priority over the other procedures which led the hip replacement market growth.

Growing osteoarthritis prevalence will fuel demand for hip replacements during projected period. Quick Uptake of Customized Hip Prostheses to Support Market Growth. The growing need for individualized implants for both men and women is expected to drive growth in the hip arthroplasty implant market. Because every patient has a different anatomy, implants come in different sizes. Regarding patient-specific implants, a lot of firms are concentrating on 3D printing technologies.

A greater knowledge of hip replacement surgery will promote the market growth during projected period. The demand for internet resources to help patients after surgery has increased due to the rise in hip replacement procedures. Healthcare institutions are quickly expanding their range of initiatives. It is predicted that the heightened knowledge of online resources would present profitable growth prospects for the industry. In recent years, patients have begun to use web-based tools and online resources to learn more about particular disorders. One such area is joint replacement, where a number of internet applications have been introduced to assist patients during their procedures, facilitate communication between patients and orthopaedic doctors, and provide post-surgery information. For example, the BMC Journal published a story in February 2020 about the RECOVER-E smartphone app, which is being developed to assist patients recuperating following hip and knee replacements.

Comprehensive Analysis of Hip Replacement Market

The hip replacement market and healthcare industry is rising at an exponential rate due to its market segmentation. This market expansion effectively provides a detailed regional assessment considering the dominant supply and demand forces that impact the pharmacy benefit management industry. These segmentations are methodically segregated by procedure and by end users. The procedure segmentation includes, Total, Partial, and Revision & Hip Resurfacing, while by End-user segmentation includes Hospitals & Ambulatory Surgery Centers, Orthopedic Clinics, and others.

The North America region lead the hip replacement market by benefitting a market size of USD 2.65 billion in 2023 due to growing number of hip replacement operations and a rise in key players' strategic alliances.

The top players in the market play a crucial role in the healthcare industry assuring industrial prospectus growth and setting market standards. These prominent market players include, Medical Device Business Services, Inc. (Johnson & Johnson Services, Inc.) (U.S.), MicroPort Scientific Corporation (China), Smith+Nephew (U.K.), Zimmer Biomet (U.S.), Exactech, Inc. (U.S.), and B. Braun SE (Germany), these market players provide a level-playing competitive environment across the globe.

In May 2023, The Ortho Q Guidance system, incorporates enhanced surgical planning for hip and knee operations, was launched by Stryker promoting market expansion.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 4.7% from 2024-2032

Unit Value (USD Billion)

Segmentation By Procedure

Total
Partial
Revision & Hip Resurfacing

By End-user

Hospitals & ASCs
Orthopedic Clinics
Others

By Geography

North America (By Procedure, End-user, and Country)
U.S. (By Procedure)
Canada (By Procedure)
Europe (By Procedure, End-user, and Country/Sub-region)
U.K. (By Procedure)
Germany (By Procedure)
France (By Procedure)
Italy (By Procedure)
Spain (By Procedure)
Scandinavia (By Procedure)
Rest of Europe (By Procedure)
Asia Pacific (By Procedure, End-user, and Country/Sub-region)
China (By Procedure)
Japan (By Procedure)
India (By Procedure)
Australia (By Procedure)
Southeast Asia (By Procedure)
Rest of Asia Pacific (By Procedure)
Latin America (By Procedure, End-user, and Country/Sub-region)
Brazil (By Procedure)
Mexico (By Procedure)
Rest of Latin America (By Procedure)
Middle East & Africa (By Procedure, End-user, and Country/Sub-region)
GCC (By Procedure)
South Africa (By Procedure)
Rest of Middle East & Africa (By Procedure)

Please Note: It will take 5-6 business days to complete the report upon order confirmation.

1. Introduction: 1.1. Research Scope; 1.2. Market Segmentation; 1.3. Research Methodology; 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics: 3.1. Market Drivers; 3.2. Market Restraints; 3.3. Market Opportunities; 3.4. Market Trends
4. Key Insights: 4.1. Number of Hip Replacement Procedures – by Key Countries, 2023; 4.2. Regulatory Scenario – by Key Countries/Regions; 4.3. Reimbursement Scenario - by Key Countries/Regions; 4.4. Technological Advancements in Hip Replacement Market; 4.5. Key Industry Developments (Mergers, Acquisitions, New Product Launches, etc.); 4.6. Impact of COVID-19 on the Market
5. Global Hip Replacement Market Analysis, Insights and Forecast, 2019-2032: 5.1. Market Analysis, Insights and Forecast – By Procedure; 5.1.1. Total; 5.1.2. Partial; 5.1.3. Revision & Hip Resurfacing; 5.2. Market Analysis, Insights and Forecast – By End-user; 5.2.1. Hospitals & ASCs; 5.2.2. Orthopedic Clinics; 5.2.3. Others; 5.3. Market Analysis, Insights and Forecast – By Region; 5.3.1. North America; 5.3.2. Europe; 5.3.3. Asia Pacific; 5.3.4. Latin America; 5.3.5. Middle East & Africa
6. North America Hip Replacement Market Analysis, Insights and Forecast, 2019-2032: 6.1. Market Analysis, Insights and Forecast – By Procedure; 6.1.1. Total; 6.1.2. Partial; 6.1.3. Revision & Hip Resurfacing; 6.2. Market Analysis, Insights and Forecast – By End-user; 6.2.1. Hospitals & ASCs; 6.2.2. Orthopedic Clinics; 6.2.3. Others; 6.3. Market Analysis, Insights and Forecast – By Country; 6.3.1. U.S.; 6.3.1.1. By Procedure; 6.3.2. Canada; 6.3.2.1. By Procedure
7. Europe Hip Replacement Market Analysis, Insights and Forecast, 2019-2032: 7.1. Market Analysis, Insights and Forecast – By Procedure; 7.1.1. Total; 7.1.2. Partial; 7.1.3. Revision & Hip Resurfacing; 7.2. Market Analysis, Insights and Forecast – By End-user; 7.2.1. Hospitals & ASCs; 7.2.2. Orthopedic Clinics; 7.2.3. Others; 7.3. Market Analysis, Insights and Forecast – By Countries/ Sub-region; 7.3.1. U.K.; 7.3.1.1. By Procedure; 7.3.2. Germany; 7.3.2.1. By Procedure; 7.3.3. France; 7.3.3.1. By Procedure; 7.3.4. Spain; 7.3.4.1. By Procedure; 7.3.5. Italy; 7.3.5.1. By Procedure; 7.3.6. Scandinavia; 7.3.6.1. By Procedure; 7.3.7. Rest of Europe; 7.3.7.1. By Procedure
8. Asia Pacific Hip Replacement Market Analysis, Insights and Forecast, 2019-2032: 8.1. Market Analysis, Insights and Forecast – By Procedure; 8.1.1. Total; 8.1.2. Partial; 8.1.3. Revision & Hip Resurfacing; 8.2. Market Analysis, Insights and Forecast – By End-user; 8.2.1. Hospitals & ASCs; 8.2.2. Orthopedic Clinics; 8.2.3. Others; 8.3. Market Analysis, Insights and Forecast – By Countries/ Sub-region; 8.3.1. Japan; 8.3.1.1. By Procedure; 8.3.2. China; 8.3.2.1. By Procedure; 8.3.3. India; 8.3.3.1. By Procedure; 8.3.4. Australia; 8.3.4.1. By Procedure; 8.3.5. Southeast Asia; 8.3.5.1. By Procedure; 8.3.6. Rest of Asia Pacific; 8.3.6.1. By Procedure
9. Latin America Hip Replacement Market Analysis, Insights and Forecast, 2019-2032: 9.1. Market Analysis, Insights and Forecast – By Procedure; 9.1.1. Total; 9.1.2. Partial; 9.1.3. Revision & Hip Resurfacing; 9.2. Market Analysis, Insights and Forecast – By End-user; 9.2.1. Hospitals & ASCs; 9.2.2. Orthopedic Clinics; 9.2.3. Others; 9.3. Market Analysis, Insights and Forecast – By Countries/ Sub regions; 9.3.1. Brazil; 9.3.1.1. By Procedure; 9.3.2. Mexico; 9.3.2.1. By Procedure; 9.3.3. Rest of Latin America; 9.3.3.1. By Procedure
10. Middle East & Africa Hip Replacement Market Analysis, Insights and Forecast, 2019-2032: 10.1. Market Analysis, Insights and Forecast – By Procedure; 10.1.1. Total; 10.1.2. Partial; 10.1.3. Revision & Hip Resurfacing; 10.2. Market Analysis, Insights and Forecast – By End-user; 10.2.1. Hospitals & ASCs; 10.2.2. Orthopedic Clinics; 10.2.3. Others; 10.3. Market Analysis, Insights and Forecast – By Countries/ Sub region; 10.3.1. South Africa; 10.3.1.1. By Procedure; 10.3.2. GCC; 10.3.2.1. By Procedure; 10.3.3. Rest of Middle East & Africa; 10.3.3.1. By Procedure
11. Competitive Analysis: 11.1. Global Market Share Analysis (2023); 11.2. Company Profiles; 11.2.1. Zimmer Biomet; 11.2.1.1. Overview; 11.2.1.2. Products & Services; 11.2.1.3. SWOT Analysis; 11.2.1.4. Recent Developments; 11.2.1.5. Strategies; 11.2.1.6. Financials (Based on Availability); 11.2.2. Medical Device Business Services, Inc. (Johnson & Johnson Services, Inc.); 11.2.2.1. Overview; 11.2.2.2. Products & Services; 11.2.2.3. SWOT Analysis; 11.2.2.4. Recent Developments; 11.2.2.5. Strategies; 11.2.2.6. Financials (Based on Availability); 11.2.3. Smith+Nephew; 11.2.3.1. Overview; 11.2.3.2. Products & Services; 11.2.3.3. SWOT Analysis; 11.2.3.4. Recent Developments; 11.2.3.5. Strategies; 11.2.3.6. Financials (Based on Availability); 11.2.4. Stryker; 11.2.4.1. Overview; 11.2.4.2. Products & Services; 11.2.4.3. SWOT Analysis; 11.2.4.4. Recent Developments; 11.2.4.5. Strategies; 11.2.4.6. Financials (Based on Availability); 11.2.5. Exactech, Inc.; 11.2.5.1. Overview; 11.2.5.2. Products & Services; 11.2.5.3. SWOT Analysis; 11.2.5.4. Recent Developments; 11.2.5.5. Strategies; 11.2.5.6. Financials (Based on Availability); 11.2.6. Gruppo Bioimpianti s.r.l.; 11.2.6.1. Overview; 11.2.6.2. Products & Services; 11.2.6.3. SWOT Analysis; 11.2.6.4. Recent Developments; 11.2.6.5. Strategies; 11.2.6.6. Financials (Based on Availability); 11.2.7. Conformis; 11.2.7.1. Overview; 11.2.7.2. Products & Services; 11.2.7.3. SWOT Analysis; 11.2.7.4. Recent Developments; 11.2.7.5. Strategies; 11.2.7.6. Financials (Based on Availability); 11.2.8. MicroPort Scientific Corporation; 11.2.8.1. Overview; 11.2.8.2. Products & Services; 11.2.8.3. SWOT Analysis; 11.2.8.4. Recent Developments; 11.2.8.5. Strategies; 11.2.8.6. Financials (Based on Availability); 11.2.9. B. Braun SE; 11.2.9.1. Overview; 11.2.9.2. Products & Services; 11.2.9.3. SWOT Analysis; 11.2.9.4. Recent Developments; 11.2.9.5. Strategies; 11.2.9.6. Financials (Based on Availability)